WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2002008435) CODON-OPTIMIZED PAPILLOMA VIRUS SEQUENCES
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2002/008435    International Application No.:    PCT/GB2001/003290
Publication Date: 31.01.2002 International Filing Date: 20.07.2001
Chapter 2 Demand Filed:    11.02.2002    
IPC:
A61K 39/00 (2006.01), C07K 14/025 (2006.01), C12N 15/67 (2006.01)
Applicants: GLAXO GROUP LIMITED [GB/GB]; Glaxo Wellcome House Berkeley Avenue Greenford Middlesex UB6 0NN (GB) (For All Designated States Except US).
ERTL, Peter, Franz [GB/GB]; (GB) (For US Only).
GOUGH, Gerald, Wayne [GB/GB]; (GB) (For US Only).
PARMAR, Vanita [GB/GB]; (GB) (For US Only).
RING, Christopher, Jeffrey, Alan [GB/GB]; (GB) (For US Only).
WALCOTT, Sarah, Marina [GB/GB]; (GB) (For US Only)
Inventors: ERTL, Peter, Franz; (GB).
GOUGH, Gerald, Wayne; (GB).
PARMAR, Vanita; (GB).
RING, Christopher, Jeffrey, Alan; (GB).
WALCOTT, Sarah, Marina; (GB)
Agent: WALKER, Ralph, Francis; GlaxoSmithKline Corporate Intellectual Property (CN9.25.1) 980 Great West Road Brentford Middlesex TW8 9GS (GB)
Priority Data:
0017990.3 21.07.2000 GB
0025802.0 20.10.2000 GB
Title (EN) CODON-OPTIMIZED PAPILLOMA VIRUS SEQUENCES
(FR) SEQUENCES DE PAPILLOMAVIRUS A CODON OPTIMISE
Abstract: front page image
(EN)The present invention relates to methods and compositions useful in the treatment and prevention of human papilloma virus infections and the symptoms and diseases associated therewith. More particularly, the invention relates to polynucleotide sequences which encode human papilloma virus (HPV) amino acid amino acid sequences, wherein the codon usage pattern of the polynucleotide sequences resemble those of highly expressed mammalian genes.
(FR)L'invention concerne des procédés et des compositions efficaces en vue de traiter et prévenir les infections par le papillomavirus ainsi que les symptômes et affections associés à ce virus. L'invention concerne en particulier des séquences de polynucléotide qui codent les séquences aminoacide/aminoacide du papillomavirus (HPV), dans lesquelles le motif d'utilisation du codon des séquences de polynucléotide ressemble à ceux des gènes de mammifères présentant une expression élevée.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)